Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

Background Little is known regarding the efficacy of immune checkpoint inhibitors (ICI) in patients with advanced large-cell neuroendocrine lung carcinoma (aLCNEC).Methods 125 consecutive patients with aLCNEC were identified in the electronic databases of 4 participating cancer centers. The patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel Kareff, Jair Bar, Amir Onn, Alona Zer, Chul Kim, Stephen V Liu, Elizabeth Dudnik, Mor Moskovitz, Anastasiya Lobachov, Teodor Gottfried, Damien Urban, Ofer Rotem, Mira Wollner
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/2/e001999.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items